18 February 2015
With a population of 420 million generating $4660 billion in GDP, Eastern Europe is swiftly gaining momentum as a key area for private and public investment in healthcare and health services, according to a new Frost & Sullivan Insights report.
Eastern Europe Healthcare Outlook 2014 points to “booming business potential for health services in 16 countries, among which Russia, Turkey, Kazakhstan, Greece, Bulgaria and the CIS”, shedding light on the changing healthcare dynamics in the region. With the number of hospitals reaching nearly 15.000 units, healthcare spending has been growing from $260 billion of 2010 to an additional 13 per cent in 2013. The percentage of private healthcare spending has also seen growth of an additional 6 per cent from 44 per cent of 2010.
Print14 March 2024
26 February 2024
NovaMedica team wishes you a Merry Christmas and a Happy New Year!
26 December 2023
Four cancer centers opened in Russia in 2023
26 April 2024
Russia and the UAE can simplify the drug registration process
26 April 2024
Big Pharma’s ROI for drug R&D saw 'welcome' rebound in 2023: report
25 April 2024
Orphan drug market to reach $270B by 2028 : Evaluate
25 April 2024